These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18684425)

  • 1. Recent advances in the genetics of diabetes.
    Pearson ER
    Prim Care Diabetes; 2008 Jun; 2(2):67-72. PubMed ID: 18684425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in diabetes genetics].
    Njølstad PR; Hertel JK; Søvik O; Raeder H; Johansson S; Molven A
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1145-9. PubMed ID: 20531501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic Diabetes: Not Your "Typical" Diabetes.
    Wiley F
    Diabetes Self Manag; 2016; 33(4):36-7. PubMed ID: 27491106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neonatal diabetes mellitus].
    Huopio H; Otonkoski T
    Duodecim; 2011; 127(6):534-41. PubMed ID: 21528518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our evolving understanding of monogenic diabetes: possibilities of improving glycaemic control following transfer from insulin to sulphonylureas.
    Shepherd M
    Prim Care Diabetes; 2008 Jun; 2(2):87-90. PubMed ID: 18684428
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
    Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea-responsive diabetes in childhood.
    Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
    J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
    Johansen A; Jensen DP; Bergholdt R; Mortensen HB; Pociot F; Nerup J; Hansen T; Pedersen O;
    Diabetes Obes Metab; 2006 Jan; 8(1):75-82. PubMed ID: 16367885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy.
    Moore AF; Florez JC
    Annu Rev Med; 2008; 59():95-111. PubMed ID: 17937592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome).
    Sumnik Z; Kolouskova S; Wales JK; Komarek V; Cinek O
    Diabet Med; 2007 Oct; 24(10):1176-8. PubMed ID: 17888143
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
    Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
    Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
    [No Abstract]   [Full Text] [Related]  

  • 13. Glibenclamide for neonatal diabetes.
    Kochar IP; Jindal R
    Indian Pediatr; 2013 Apr; 50(4):428-9. PubMed ID: 23665609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Search for type 2 diabetes susceptibility genes].
    Hirota Y; Kasuga M
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2084-9. PubMed ID: 16411434
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis in diabetes: does it matter?
    Thethy I; Robertson L; Swaminathan K
    J R Coll Physicians Edinb; 2011 Jun; 41(2):119-21. PubMed ID: 21677915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
    Mlynarski W; Tarasov AI; Gach A; Girard CA; Pietrzak I; Zubcevic L; Kusmierek J; Klupa T; Malecki MT; Ashcroft FM
    Nat Clin Pract Neurol; 2007 Nov; 3(11):640-5. PubMed ID: 17982434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte nuclear factor 4α gene mutation associated with familial neonatal hyperinsulinism and maturity-onset diabetes of the young.
    Pingul MM; Hughes N; Wu A; Stanley CA; Gruppuso PA
    J Pediatr; 2011 May; 158(5):852-4. PubMed ID: 21353246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of type 2 diabetes mellitus: status and perspectives.
    Hansen L; Pedersen O
    Diabetes Obes Metab; 2005 Mar; 7(2):122-35. PubMed ID: 15715885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes.
    Vaxillaire M; D P; Bonnefond A; Froguel P
    Pediatr Endocrinol Rev; 2009 Mar; 6(3):405-17. PubMed ID: 19396026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.